ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue124,90117,33161
Cost of Revenue13,0604,4062,500
Gross Profit111,84112,925-2,439
Operating Expenses
Research Development149,18999,28473,869
Selling General and Administrative255,062186,45688,304
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-292,410-272,815-164,612
Income from Continuing Operations
Total Other Income/Expenses Net4,1262,763499
Earnings Before Interest and Taxes-288,284-270,052-164,113
Interest Expense---
Income Before Tax-288,284-270,052-164,113
Income Tax Expense1,1191,341330
Minority Interest---
Net Income From Continuing Ops-289,403-271,393-164,443
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-289,403-271,393-164,443
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-289,403-271,393-164,443